-
Something wrong with this record ?
Azithromycin promotes proliferation, and inhibits inflammation in nasal epithelial cells in primary ciliary dyskinesia
Z. Varenyiova, LS. Rojas-Hernandez, J. Spano, V. Capek, Y. Rosenberg-Hasson, T. Holmes, C. Milla
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
Nature Open Access
from 2011-12-01
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
Springer Nature OA/Free Journals
from 2011-12-01
- MeSH
- Azithromycin * pharmacology MeSH
- Cytokines MeSH
- Epithelial Cells MeSH
- Humans MeSH
- Lipopolysaccharides toxicity MeSH
- Ciliary Motility Disorders * MeSH
- Cell Proliferation MeSH
- Inflammation drug therapy MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Primary ciliary dyskinesia (PCD) is a genetic disorder associated with recurrent and chronic respiratory infections due to functional defects of motile cilia. In this study, we aimed to elucidate inflammatory and proliferative responses in PCD respiratory epithelium and evaluate the effect of Azithromycin (AZT) on these responses. Airway basal cells (BCs) were isolated from nasal samples of Wild-type (WT) epitope of healthy donors and PCD donors with bi-allelic mutations in DNAH5, DNAH11 and CCDC39. Cells were expanded in vitro and stimulated with either Lipopolysaccharide (LPS) or vehicle control. Post stimulation, cells were treated with either Azithromycin (AZT) or vehicle control. Cell proliferation was imaged in real-time. Separately, BCs from the same donors were expanded and grown at an air-liquid interface (ALI) to generate a multi-ciliated epithelium (MCE). Once fully mature, cells were stimulated with LPS, AZT, LPS + AZT or vehicle control. Inflammatory profiling was performed on collected media by cytokine Luminex assay. At baseline, there was a significantly higher mean production of pro-inflammatory cytokines by CCDC39 BCs and MCEs when compared to WT, DNAH11 and DNAH5 cells. AZT inhibited production of cytokines induced by LPS in PCD cells. Differences in cell proliferation were noted in PCD and this was also corrected with AZT treatment.
Center for Excellence in Pulmonary Biology Stanford University Palo Alto CA USA
Human Immune Monitoring Center Stanford University Stanford CA USA
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016294
- 003
- CZ-PrNML
- 005
- 20231026110042.0
- 007
- ta
- 008
- 231013s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-023-41577-5 $2 doi
- 035 __
- $a (PubMed)37660113
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Varenyiova, Zofia $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. z.varenyiova@gmail.com
- 245 10
- $a Azithromycin promotes proliferation, and inhibits inflammation in nasal epithelial cells in primary ciliary dyskinesia / $c Z. Varenyiova, LS. Rojas-Hernandez, J. Spano, V. Capek, Y. Rosenberg-Hasson, T. Holmes, C. Milla
- 520 9_
- $a Primary ciliary dyskinesia (PCD) is a genetic disorder associated with recurrent and chronic respiratory infections due to functional defects of motile cilia. In this study, we aimed to elucidate inflammatory and proliferative responses in PCD respiratory epithelium and evaluate the effect of Azithromycin (AZT) on these responses. Airway basal cells (BCs) were isolated from nasal samples of Wild-type (WT) epitope of healthy donors and PCD donors with bi-allelic mutations in DNAH5, DNAH11 and CCDC39. Cells were expanded in vitro and stimulated with either Lipopolysaccharide (LPS) or vehicle control. Post stimulation, cells were treated with either Azithromycin (AZT) or vehicle control. Cell proliferation was imaged in real-time. Separately, BCs from the same donors were expanded and grown at an air-liquid interface (ALI) to generate a multi-ciliated epithelium (MCE). Once fully mature, cells were stimulated with LPS, AZT, LPS + AZT or vehicle control. Inflammatory profiling was performed on collected media by cytokine Luminex assay. At baseline, there was a significantly higher mean production of pro-inflammatory cytokines by CCDC39 BCs and MCEs when compared to WT, DNAH11 and DNAH5 cells. AZT inhibited production of cytokines induced by LPS in PCD cells. Differences in cell proliferation were noted in PCD and this was also corrected with AZT treatment.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a azithromycin $x farmakologie $7 D017963
- 650 _2
- $a lipopolysacharidy $x toxicita $7 D008070
- 650 _2
- $a epitelové buňky $7 D004847
- 650 _2
- $a zánět $x farmakoterapie $7 D007249
- 650 _2
- $a proliferace buněk $7 D049109
- 650 _2
- $a cytokiny $7 D016207
- 650 12
- $a poruchy ciliární motility $7 D002925
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Rojas-Hernandez, Laura S $u Center for Excellence in Pulmonary Biology, Stanford University, Palo Alto, CA, USA
- 700 1_
- $a Spano, Jacquelyn $u Center for Excellence in Pulmonary Biology, Stanford University, Palo Alto, CA, USA
- 700 1_
- $a Capek, Vaclav $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Rosenberg-Hasson, Yael $u Human Immune Monitoring Center, Stanford University, Stanford, CA, USA
- 700 1_
- $a Holmes, Tyson $u Human Immune Monitoring Center, Stanford University, Stanford, CA, USA
- 700 1_
- $a Milla, Carlos $u Center for Excellence in Pulmonary Biology, Stanford University, Palo Alto, CA, USA
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 13, č. 1 (2023), s. 14453
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37660113 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026110037 $b ABA008
- 999 __
- $a ok $b bmc $g 2000047 $s 1202656
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 13 $c 1 $d 14453 $e 20230902 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20231013